Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31049762 | 1.00 | PTGER4 (1.00) | PTGER4PTGER2 | |
| SCHEMBL120617 | 1.00 | PTGER4 (1.00) | PTGER4PTGER2 | |
| SCHEMBL29373541 | 1.00 | PTGER4 (1.00) | PTGER4PTGER2 | |
| SCHEMBL5357769 | 0.92 | PTGER4 (0.85) | PTGER4PTGER2 | |
| SCHEMBL4448664 | 0.92 | PTGER4 (0.84) | PTGER4PTGER2 | |
| SCHEMBL691838 | 0.92 | PTGER4 (1.00) | PTGER4PTGER2 | |
| SCHEMBL19713765 | 0.92 | PTGER4 (1.00) | PTGER4PTGER2 | |
| SCHEMBL19713723 | 0.92 | PTGER4 (0.85) | PTGER4PTGER2 | |
| SCHEMBL1284715 | 0.92 | PTGER4 (0.85) | PTGER4PTGER2 | |
| SCHEMBL691746 | 0.90 | PTGER4 (0.88) | PTGER4PTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115697317-A | Use of EP4 receptor antagonists for the treatment of liver cancer, melanoma, lymphoma and leukemia | 株式会社AskAt | 2023-02-03 | — | — | CN | claimed |
| CN-108289960-B | Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer | 株式会社AskAt | 2021-07-09 | — | — | CN | claimed |
| CN-117940166-A | SOS1 inhibitors and RAS inhibitors for the treatment of pain | 塞文莱斯治疗有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-112689629-B | For inhibiting Nav1.8 Pyridazine Compounds | 利伯研究所公司 | 2024-04-23 | — | — | CN | disclosed |
| CN-117858875-A | Hydroxy-and (halo) alkoxy-substituted tetrahydrofurans as sodium channel modulators | 沃泰克斯药物股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117813302-A | Substituted tetrahydrofuran-2-carboxamides as sodium channel modulators | 沃泰克斯药物股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117794920-A | N- (hydroxyalkyl (hetero) aryl) tetrahydrofurancarboxamides as sodium channel modulators | 沃泰克斯药物股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117794918-A | Substituted tetrahydrofuran analogues as sodium channel modulators | 沃泰克斯药物股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117794919-A | N- (hydroxyalkyl (hetero) aryl) tetrahydrofurancarboxamide analogues as sodium channel modulators | 沃泰克斯药物股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117616022-A | Crystalline forms | 拉夸里亚创药株式会社 | 2024-02-27 | — | — | CN | disclosed |
| CN-111868037-B | Fused cyclic urea derivatives as CRHR2 antagonists | 拉夸里亚创药株式会社 | 2023-10-13 | — | — | CN | disclosed |
| CN-101616896-A | Tricyclic compounds and as the purposes of glucocorticoid receptor modulator | PFIZER PROD INC | 2009-12-30 | — | — | CN | disclosed |
| CN-101595102-A | Diaryl ether urea compounds | PFIZER PROD INC (US) | 2009-12-02 | — | — | CN | disclosed |
| CN-101356169-A | Pyrazine derivatives | PFIZER LTD (GB) | 2009-01-28 | — | — | CN | disclosed |
| CN-101321738-A | Spirocyclic derivatives | PFIZER LTD (GB) | 2008-12-10 | — | — | CN | disclosed |
| CN-101233139-A | Alpha-(aryl-or heteroaryl-methyl)-beta-piperidinopropanoic acid compounds as ORL1-receptor antagonists | PFIZER (US) | 2008-07-30 | — | — | CN | disclosed |
| CN-101198606-A | Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as ORL1-receptor antagonists | PFIZER JAPAN INC (US) | 2008-06-11 | — | — | CN | disclosed |
| CN-101160285-A | Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists | PFIZER (US) | 2008-04-09 | — | — | CN | disclosed |
| CN-101065355-A | N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors | PFIZER (US) | 2007-10-31 | — | — | CN | disclosed |
| CN-1989107-A | Pyridine derivatives | PFIZER (US) | 2007-06-27 | — | — | CN | disclosed |